These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16054578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR, Wade TJ, Levy DA, Colford JM, Hilton JF.
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial.
    Piaggio G, Elbourne D, Schulz KF, Villar J, Pinol AP, Gülmezoglu AM, WHO Research Group to evaluate Misoprostol in the Management of the Third Stage of Labour.
    BMC Med Res Methodol; 2003 Oct 03; 3():19. PubMed ID: 14525622
    [Abstract] [Full Text] [Related]

  • 6. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A, Forfang E, Haahr MT, Als-Nielsen B, Brorson S.
    Int J Epidemiol; 2007 Jun 03; 36(3):654-63. PubMed ID: 17440024
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep 03; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I, Estellat C, Ravaud P.
    J Clin Epidemiol; 2005 Dec 03; 58(12):1220-6. PubMed ID: 16291465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A, Boutron I.
    Clin Pharmacol Ther; 2011 Nov 03; 90(5):732-6. PubMed ID: 21993424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study.
    Hsu VM, Khanna D, Smith E, Filemon T, Whelton S, Lopata M, Davis JC, Polito A, Heck L, Molitor J, Abeles M, Granda J, Korn J, Clements P, Scleroderma Lung Study Group.
    Clin Trials; 2010 Feb 03; 7(1):85-9. PubMed ID: 20032002
    [Abstract] [Full Text] [Related]

  • 17. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R, Boon H.
    Complement Ther Clin Pract; 2006 May 03; 12(2):91-6. PubMed ID: 16648085
    [Abstract] [Full Text] [Related]

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 03; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 19. Rater bias in a blinded randomized placebo-controlled psychiatry trial.
    Marcus SM, Gorman JM, Tu X, Gibbons RD, Barlow DH, Woods SW, Katharine Shear M.
    Stat Med; 2006 Aug 30; 25(16):2762-70. PubMed ID: 16345016
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.